NGL Fine Chem Quarterly Results for Trading Insights

NGLFINE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹10 Cr
QSept 2025
Quarterly Results

NGL Fine Chem Quarterly Results Key Highlights

  • Revenue of ₹122 Cr in Sept 2025 (+29.8% vs Mar 2025, +23.2% vs Sept 2024)
  • Net Profit of ₹10 Cr in Sept 2025 (+900.0% vs Mar 2025, +0.0% vs Sept 2024)
  • EBITDA of ₹19 Cr in Sept 2025 (+280.0% vs Mar 2025)
  • Operating Margin of 14.0% in Sept 2025 (+7.0pp vs Mar 2025)
  • Earnings Per Share of ₹15.58 in Sept 2025 (+1670.5% vs Mar 2025)

NGL Fine Chem Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 122 94 111 132 99 29.8% 23.2%
Net Profit (₹ Cr) 10 1 9 16 10 - -
EBITDA (₹ Cr) 19 5 17 27 17 - -
EPS (₹) 15.58 0.88 14.96 25.40 15.88 - -
Operating Margin (%) 14.0% 7.0% 11.0% 18.0% 12.0% - -

NGL Fine Chem Share Price Trend Around Quarterly Results

Visualize NGL Fine Chem's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for NGL Fine Chem

Additional stock information and data for NGLFINE

NGLFINE share price
NGLFINE earnings multiple
NGLFINE yearly price range

Profitability Ratios

Profit Margin 8.2%
EBITDA Margin 15.6%
Operating Margin 14.0%
ROE (Annual) 14.2%

Balance Sheet Highlights

Total Assets ₹433 Cr
Total Equity ₹282 Cr
Current Assets ₹235 Cr
Current Liabilities ₹32 Cr

Cash Flow Analysis

Operating Cash Flow ₹36 Cr
Investing Cash Flow ₹-35 Cr
Financing Cash Flow ₹-1 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹2331.40
Exchange NSE
Last Updated Apr 08, 2026

Revenue Trend (₹ Cr)

Dec 2025 132
Jun 2025 111
Mar 2025 94
Sept 2025 122

Net Profit Trend (₹ Cr)

Dec 2025 16
Jun 2025 9
Mar 2025 1
Sept 2025 10

Operating Margin Trend (%)

Dec 2025 18.0%
Jun 2025 11.0%
Mar 2025 7.0%
Sept 2025 14.0%

Sector Competitors - Quarterly Performance Comparison

Comparing NGL Fine Chem quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1714.6 14,875 3,125 +10.8% - 21.0% 131.9
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5882.0 2,860 689 +7.1% - 24.1% 226.5
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4029.2 3,219 591 +11.3% - 18.4% 229.7
Lupin
Sept 2025 		₹102,578.78 Cr 2294.1 6,921 1,485 +23.2% - 21.5% 70.9
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1191.4 9,135 1,337 +1.1% - 14.6% 73.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores